Since the Ministry of Agriculture and Rural Affairs of our country fully implemented the "feed ban on antibiotics" policy, the research and approval process of veterinary traditional Chinese medicine has significantly accelerated. A series of innovative veterinary products have been approved for use in animal disease prevention and treatment, promoting the development of green farming. However, at present, the research and application of veterinary traditional Chinese medicine still face key challenges, such as insufficient coverage of target animals (such as ruminants, aquatic animals, and pet medication is scarce), incomplete quality standard system, lack of toxicity evaluation methods, and lack of systematic clinical data, which seriously restrict its modernization and internationalization process. This study systematically analyzed the new veterinary traditional Chinese medicine drugs and preparations approved in China from January 2006 to December 2024, evaluated their research trends, indication distribution, target animal coverage and quality standards, and revealed existing problems and proposed countermeasures to promote the standardization, modernization and internationalization of veterinary traditional Chinese medicine. Based on the "National Veterinary Drug Basic Database" and "Agriculture and Rural Affairs Department Announcements", this study collected approved veterinary traditional Chinese medicine data, conducted a comprehensive analysis from the dimensions of research trends, indications, target animals and formulation innovation, and combined with literature and policies to assess their innovation potential. The study found: (1) The number of research and development has continued to increase, but the target animals were concentrated on pigs and poultry (accounting for > 80%), while ruminants, aquatic animals and pet medication were less than 25%; (2) The indications were mainly respiratory/digestive tract diseases and immune regulation, and antiviral drugs were scarce; (3) The standardization degree of production processes was low, and the quality of raw materials fluctuated greatly; (4) Some innovative products (such as Astragalus polysaccharide injection, Forsythia extract preparations) showed high scientific value, but the overall research level still lagged significantly behind chemical drugs and biological products. Veterinary traditional Chinese medicine had great potential in green and healthy farming, but it needed to overcome the following bottlenecks: (1) strengthen basic research to clarify the pharmacological basis of the drug; (2) establish a full-chain quality control system; (3) expand the target animal range and develop new drugs for anti-viral and metabolic diseases; (4) build toxicity evaluation standards that conform to the characteristics of traditional Chinese medicine; (5) promote collaborative innovation among industry, academia and research institutions and international standard formulation. By integrating traditional medical theory with modern technology, veterinary traditional Chinese medicine is expected to build a safer and more efficient animal disease prevention and control system, providing a Chinese solution for the global "antibiotic reduction" initiative.
- Article type
- Year
- Co-author
The study mainly made the bioinformatics analysis, carried out prokaryotic expression, and explored the metal binding characterization of Sus scrofa metallothionein-1A (SsMT-1A) and metallothionein-2A (SsMT-2A) with Zn(Ⅱ) and Cu(Ⅰ), so as to provide a theoretical basis for the study of the mechanism of action of adding Zn and Cu in diet inducing porcine metallothionein expression, thereby regulating the Zn and Cu homeostasis in vivo, and then promoting the porcine production performance.
Firstly, the porcine gene sequences of SsMT-1A and SsMT-2A were obtained from NCBI. Afterwards, their protein sequence characteristics were analyzed by ClustalX2 software and ExPASy database, and then the phylogenetic tree of MT protein molecular was constructed between them and other species using the Mega-X. Secondly, the prokaryotic expression vector pET-28a-SUMO-SsMT-1A/SsMT-2A were constructed and verified by PCR, double digestion, and gene sequencing. Subsequently, the recombinant plasmid was transformed into BL21(DE3) plysS and the expression of SsMT-1A and SsMT-2A was induced using the IPTG. Then, the SUMO-SsMT-1A/SsMT-2A recombinant protein were purified by Ni-NTA affinity chromatography and Superdex-75 column, and were analyzed by Western-blot. In the end, the properties of SsMT-1A and SsMT-2A binding Zn(Ⅱ) and Cu(Ⅰ) were surveyed by the tolerance analysis of Escherichia coli containing SsMT-1A and SsMT-2A genes, circular dichroism (CD), matrix assisted laser analytic ionization time of flight mass spectrometry (MALDI-TOF-MS), and isothermal micrometer calorimetry (ITC).
Bioinformatics analysis showed that the protein sequences of SsMT-1A and SsMT-2A were highly homologous, and their cysteine (Cys) content and arrangement motifs were perfectly consistent, and there existed only 8 amino acid residues discrepancy. Through the prokaryotic expression, purification, and SUMO enzyme digestion, the SsMT-1A/SsMT-2A fusion protein were successfully obtained. The tolerance analysis of metal demonstrated that compared with SsMT-2A, E. coli containing SsMT-1A genes had the stronger resistance to Zn and Cu. The CD spectrum illustrated that SsMT-1A and SsMT-2A could combine with Zn(Ⅱ) and Cu(Ⅰ) and both of them exhibited the preference with Zn(Ⅱ) coordination. But SsMT-1A exhibited the stronger binding ability with Zn(Ⅱ) than SsMT-2A. MALDI-TOF-MS results showed that the experimental molecular weights of apo-SsMT-1A and apo-SsMT-2A were respective 6 047.5 Da and 6 048 Da, and the stability order of both of them was and Cu(Ⅰ)> Zn(Ⅱ). ITC results showed that the affinity constants of SsMT-1A and SsMT-2A coordinating Cu(Ⅰ) were higher than that of Zn(Ⅱ), and the stoichiometries of both of them binding Cu(Ⅰ) were 7, while the stoichiometry of SsMT-1A binding Zn(Ⅱ) was 2.
Although SsMT-1A and SsMT-2A possessed the high homology, the difference of 8 amino acid residues determined their different binding feature with Zn(Ⅱ) and Cu(Ⅰ). Although SsMT-1A and SsMT-2A shared a highly consistent binding behavior of Zn(Ⅱ) and Cu(Ⅰ), their characteristics of binding Zn(Ⅱ) and Cu(Ⅰ) was slightly different. Thus, they should not be considered as completely physiological equivalent molecules. According to the relationship of structure and function of MT, SsMT-1A might play a role in detoxification of heavy metal ions and SsMT-2A might mainly regulate Zn homeostasis. The study laid a foundation for further elucidating the role of SsMT-1A and SsMT-2A in regulating metal ion homeostasis to promote pig production performance.
京公网安备11010802044758号